AbbVie (ABBV) originated as a spin-off of Abbott Laboratories nearly a decade ago, and in doing so, inherited its predecessor's dividend history. AbbVie holds a coveted spot on the list of Dividend Kings. The stock, which currently yields 3.6% for investors, has seen its dividend rise by approximately 270% in the decade since it became an independent company. In turn, the stock has delivered a total return of 606% for investors in that same period. In a challenging macro environment where consumers are regulating their spending, you're not alone if you find yourself shying away from stocks that might be directly impacted by these trends. However, a household name and consumer staples giant like Kimberly-Clark (KMB) has the staying power to ride out the current environment and beyond.
Source: Motley Fool
Related Articles:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.